Investigational Drug Information for IW-1701
✉ Email this page to a colleague
What is the drug development status for IW-1701?
IW-1701 is an investigational drug.
There have been 6 clinical trials for IW-1701.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 22nd 2017.
The most common disease conditions in clinical trials are Anemia, Sickle Cell, Esophageal Achalasia, and [disabled in preview]. The leading clinical trial sponsors are Cyclerion Therapeutics, Ironwood Pharmaceuticals, Inc., and [disabled in preview].
There are four US patents protecting this investigational drug and forty-seven international patents.
Summary for IW-1701
| US Patents | 4 |
| International Patents | 47 |
| US Patent Applications | 16 |
| WIPO Patent Applications | 6 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2017-12-22) |
| Vendors | 9 |
Recent Clinical Trials for IW-1701
| Title | Sponsor | Phase |
|---|---|---|
| A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers | Cyclerion Therapeutics | Phase 1 |
| A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers | Ironwood Pharmaceuticals, Inc. | Phase 1 |
| A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Olinciguat in Healthy Male Volunteers | Cyclerion Therapeutics | Phase 1 |
Clinical Trial Summary for IW-1701
Top disease conditions for IW-1701
Top clinical trial sponsors for IW-1701
US Patents for IW-1701
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| IW-1701 | See Plans and Pricing | sGC stimulators | Ironwood Pharmaceuticals, Inc. (Cambridge, MA) | See Plans and Pricing |
| IW-1701 | See Plans and Pricing | sGC stimulators | Cyclerion Therapeutics, Inc. (Cambridge, MA) | See Plans and Pricing |
| IW-1701 | See Plans and Pricing | sGC stimulators | IRONWOOD PHARMACEUTICALS, INC. (Cambridge, MA) | See Plans and Pricing |
| IW-1701 | See Plans and Pricing | sGC stimulators | IRONWOOD PHARMACEUTICALS, INC. (Cambridge, MA) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for IW-1701
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| IW-1701 | Australia | AU2014227862 | 2033-03-15 | See Plans and Pricing |
| IW-1701 | Australia | AU2019203606 | 2033-03-15 | See Plans and Pricing |
| IW-1701 | Australia | AU2021204292 | 2033-03-15 | See Plans and Pricing |
| IW-1701 | Brazil | BR112015023349 | 2033-03-15 | See Plans and Pricing |
| IW-1701 | Canada | CA2907111 | 2033-03-15 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
